Skip to content

TTRX TTRX Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Journey Medical Corporation logo
Journey Medical CorporationDERM
$88K-50.6%
PTH
Pelthos Therapeutics Inc.PTHS
$3.15M
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$2.01M-42.7%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$4.36M+137%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$41.74M-10.7%
PVL
Palvella TherapeuticsPVLA
$528K

Other financials

Income statement

See full
Operating income-$1.2M-224%
Net income-$971.0K-196%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$11.2M+613%
Total debt$6.0M
Total equity$6.1M+647%
Total assets$18.6M

Cash flow

See full
Operating cash flow-$1.6M-448%

Valuation

See full
Market cap$217.45M-17.7%
Enterprise value$212.24M

Returns & leverage

See full
Return on equity-118.8%
Debt / equity
Current ratio2.2×

Where this comes from

Reported directly by TTRX in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TTRX's operating lease ROU assets?
TTRX (TTRX) reported operating lease ROU assets of $67.57K in Q1 2026.
What does operating lease ROU assets mean?
This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.